Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Company news > 2024 > AACR 2024

AACR 2024

AACR 2024

AACR 2024

Excited for AACR 2024, we invite you to meet our executive team, led by CEO Bill Farley.

It's a pivotal moment to discuss the evolving landscape of oncology research. Let’s shape the future of oncology together.

See you there for insightful discussions and potential partnerships!

Read also

Gossamer Bio
Gossamer Bio
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Amgen opens new drug substance
Amgen opens new drug substance
Amgen opens new drug substance facility in North Carolina, US
BIA report
BIA report
BIA report: UK biotech investment surged to £3.5bn in 2024
MSD wins FDA
MSD wins FDA
MSD wins FDA priority review for Welireg in rare endocrine cancer
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Natural base
Virtual space
Drug Discovery Services
AI Kinome Profile
Al/ML Data sets
Synthetic and Medicinal Chemistry
In silico drug design (CADD)
Discovery biology
ADME, DMPK
Functional ex vivo and in vivo models
Safety and Toxicology
Company
News & Media
Contact us
Trends in discovery compounds

We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.

Accept